Clinical Trial Update: Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of gemcitabine and vinorelbine in soft tissue sarcoma has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Gemzar (gemcitabine)
• Navelbine (vinorelbine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: COMPLETED